News

A new building for the Institute for Lung Health (ILH) is being constructed at the DZL site in Gießen, Marburg, Bad Nauheim.

Professor Rajkumar Savai, MD, was awarded the Thoracic Oncology “Mid-Career Achievement Award” for his significant and meaningful contribution to thoracic oncology research at the 2023 Annual Meeting of the American Thoracic Society (ATS) International Conference in Washington, DC, USA.

Vom 25.-28. Mai 2022 präsentierte sich das DZL mit Informationsstand, Vorträgen, Postern und weiteren Aktionen beim 62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP) in Leipzig.

Vier von sechs Deutschen Zentren der Gesundheitsforschung (DZG) feierten gestern mit einem Festakt in Berlin und rund 300 Gästen aus Politik und Wissenschaft ihren zehnten Geburtstag.

Thanks to million euro funding from the state of Hesse, Corona expert Susanne Herold remains at Justus Liebig University Giessen.

DZL scientists identified a new player within the pressure regulation in pulmonary vessels

Further funding of clinical studies by the DZL in 2022. Two studies were successful in this year's application round.

DZL scientists discover novel, attractive therapeutic strategy to treat PH with an active ingredient from the walnut.

Prof. Dr. Dr. Friedrich Grimminger was awarded the Von Behring Röntgen Research Medal for his life's work, and Dr. Niklas Gremke received a Von Behring Röntgen Young Investigator Award.

Wissenschaftler des DZL-Standortverbundes UGMLC haben entdeckt, dass die Substanz Thapsigargin die Vermehrung von SARS-CoV-2 hemmt.

In der FAZ ist ein Interview mit Professorin Susanne Herold vom DZL-Standort UGMLC über die Corona-Impfung und die aktuelle Lage in den Krankenhäusern erschienen.

A collaboration of multiple research institutions with researchers of the DZL site Munich involved reveals the cellular activation states of SARS-CoV-2 reactive T cells in the lung and blood. The study was published in Nature Communications.